Advanced search
Publication Cover
Clinical and Experimental Gastroenterology Volume 13, 2020 - Issue
Submit an article Journal homepage
286
Views
15
CrossRef citations to date
0
Altmetric
Review

Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors

Edoardo TronconeDepartment of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy
,
Irene MarafiniDepartment of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy
,
Giovanna Del Vecchio BlancoDepartment of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-6327-563X
ORCID Icon,
Antonio Di GraziaDepartment of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy
&
Giovanni MonteleoneDepartment of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
Pages 131-139 | Published online: 05 May 2020

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Silvia Salvatori, Benedetto Neri, Irene Marafini, Mattia Brigida & Giovanni Monteleone. (2023) Emerging oral drug options for ulcerative colitis. Expert Opinion on Emerging Drugs 0:0, pages 1-11.
Read now

Articles from other publishers (14)

Ivan Voitalov, Lixia Zhang, Casey Kilpatrick, Johanna B. Withers, Alif Saleh, Viatcheslav R. Akmaev & Susan Dina Ghiassian. (2022) The module triad: a novel network biology approach to utilize patients’ multi-omics data for target discovery in ulcerative colitis. Scientific Reports 12:1.
Crossref
Jeong-Hun Lee, Kyung-Sook Chung, Ji-Sun Shin, Seang-Hwan Jung, Sangmin Lee, Myung-Ki Lee, Hee-Do Hong, Young Kyoung Rhee & Kyung-Tae Lee. (2022) Anti-Colitic Effect of an Exopolysaccharide Fraction from Pediococcus pentosaceus KFT-18 on Dextran Sulfate Sodium-Induced Colitis through Suppression of Inflammatory Mediators. Polymers 14:17, pages 3594.
Crossref
Alexandros Toskas & Ayesha Akbar. (2022) IBD therapeutics: what is in the pipeline?. Frontline Gastroenterology 13:e1, pages e35-e43.
Crossref
Anna Kofla-Dłubacz, Katarzyna Akutko, Elżbieta Krzesiek, Tatiana Jamer, Joanna Braksator, Paula Grębska, Tomasz Pytrus & Andrzej Stawarski. (2022) Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases. Journal of Clinical Medicine 11:4, pages 994.
Crossref
Sara M. Parigi, Ludvig Larsson, Srustidhar Das, Ricardo O. Ramirez Flores, Annika Frede, Kumar P. Tripathi, Oscar E. Diaz, Katja Selin, Rodrigo A. Morales, Xinxin Luo, Gustavo Monasterio, Camilla Engblom, Nicola Gagliani, Julio Saez-Rodriguez, Joakim Lundeberg & Eduardo J. Villablanca. (2022) The spatial transcriptomic landscape of the healing mouse intestine following damage. Nature Communications 13:1.
Crossref
Jianqiu Xiao, Kai Sun, Chun Wang, Yousef Abu-Amer & Gabriel Mbalaviele. (2022) Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis. Journal of Translational Autoimmunity 5, pages 100162.
Crossref
Yi Li, Jianping Chen, Andrew A Bolinger, Haiying Chen, Zhiqing Liu, Yingzi Cong, Allan R Brasier, Irina V Pinchuk, Bing Tian & Jia Zhou. (2021) Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 27:Supplement_2, pages S38-S62.
Crossref
Isabel Garrido, Susana Lopes & Guilherme Macedo. (2021) Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 27:12, pages 2010-2022.
Crossref
Daxin Guo, Ke Jiang, Jiaze Hong, Mengting Zhang, Yetan Shi & Bin Zhou. (2021) Association between vedolizumab and postoperative complications in IBD: a systematic review and meta-analysis. International Journal of Colorectal Disease 36:10, pages 2081-2092.
Crossref
Mingming Zhu & Zhihua Ran. (2021) Clinical characteristics of ulcerative colitis in elderly patients. JGH Open 5:8, pages 849-854.
Crossref
Ritesh M. Pabari, Murtaza M. Tambuwala, Natalia Lajczak-McGinley, Alaa Aljabali, Brian P. Kirby, Stephen Keely & Zebunissa Ramtoola. (2021) Novel polyurethane based particulate formulations of infliximab reduce inflammation in DSS induced murine model of colitis – A preliminary study. International Journal of Pharmaceutics 604, pages 120717.
Crossref
Alessandro Armuzzi & Giuseppina Liguori. (2021) Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review. Digestive and Liver Disease 53:7, pages 803-808.
Crossref
Natalia KOZAK, Olena BARABANCHYK, Mariia SOBCHENKO, Nataliia MOLOCHEK, Nadiia DOLGAIA, Yuri PENCHUK & Galyna MYKHALCHYSHYN. (2021) Application features of biological therapy in patients with autoimmune diseases. Minerva Biotechnology and Biomolecular Research 33:2.
Crossref
Laurent Peyrin-Biroulet, William J. Sandborn, Remo Panaccione, Eugeni Domènech, Lieven Pouillon, Britta Siegmund, Silvio Danese & Subrata Ghosh. (2021) Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therapeutic Advances in Gastroenterology 14, pages 175628482110599.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.